A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

PHASE3CompletedINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Lung Cancer

Interventions

DRUG

Uridine 5'-Triphosphate (UTP) Solution for Inhalation

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00210080 - A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) | Biotech Hunter | Biotech Hunter